$2.36T
Total marketcap
$82.62B
Total volume
BTC 50.54%     ETH 14.73%
Dominance

Regnum RGMP Stock

0.0001 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
2.3K USD
LOW - HIGH [24H]
0.0001 - 0.0001 USD
VOLUME [24H]
600 USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.03 USD

Regnum Price Chart

Regnum RGMP Financial and Trading Overview

Regnum stock price 0.0001 USD
Previous Close 0.15 USD
Open 0.15 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.15 - 0.15 USD
52 Week Range 0.1 - 0.8 USD
Volume 1.59K USD
Avg. Volume 2.41K USD
Market Cap 3.44M USD
Beta (5Y Monthly) 3.336286
PE Ratio (TTM) N/A
EPS (TTM) -0.03 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

RGMP Valuation Measures

Enterprise Value 4.55M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Regnum Stock Price History

Beta (5Y Monthly) 3.336286
52-Week Change -37.50%
S&P500 52-Week Change 20.43%
52 Week High 0.8 USD
52 Week Low 0.1 USD
50-Day Moving Average 0.23 USD
200-Day Moving Average 0.18 USD

RGMP Share Statistics

Avg. Volume (3 month) 2.41K USD
Avg. Daily Volume (10-Days) 159 USD
Shares Outstanding 22.95M
Float 269.89K
Short Ratio N/A
% Held by Insiders 98.82%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -42.018%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -693705 USD
Diluted EPS (ttm) -0.03
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 462.37K USD
Total Cash Per Share (mrq) 0.02 USD
Total Debt (mrq) 1.57M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.269
Book Value Per Share (mrq) -0.059

Cash Flow Statement

Operating Cash Flow (ttm) -937733 USD
Levered Free Cash Flow (ttm) -687501 USD

Profile of Regnum

Country United States
State NY
City New York
Address 600 Third Avenue
ZIP 10016
Phone 877 313 2232
Website N/A
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 1

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.

Q&A For Regnum Stock

What is a current RGMP stock price?

Regnum RGMP stock price today per share is 0.0001 USD.

How to purchase Regnum stock?

You can buy RGMP shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Regnum?

The stock symbol or ticker of Regnum is RGMP.

Which industry does the Regnum company belong to?

The Regnum industry is Biotechnology.

How many shares does Regnum have in circulation?

The max supply of Regnum shares is 22.95M.

What is Regnum Price to Earnings Ratio (PE Ratio)?

Regnum PE Ratio is now.

What was Regnum earnings per share over the trailing 12 months (TTM)?

Regnum EPS is -0.03 USD over the trailing 12 months.

Which sector does the Regnum company belong to?

The Regnum sector is Healthcare.